drug

Alzheimer's drug clinical trial halted after nine deaths

Monday, May 10, 2010 by: David Gutierrez, staff writer
Tags: Alzheimer's, drug trials, health news

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
Malaysia Airlines Flight 370 now clearly a government cover-up: All evidence contradicts official story
White House admits staging fake vaccination operation to gather DNA from the public
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Russia taking McDonald's to court, threatens countrywide shutdown
Why does the CDC own a patent on Ebola 'invention?'
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Oregon man serving prison sentence for collecting rainwater on his own property
U.S. treating meat with ammonia, bleach and antibiotics to kill the '24-hour sickness'
Ebola outbreak may already be uncontrollable; Monsanto invests in Ebola treatment drug company as pandemic spreads
Ben and Jerry's switches to non-GMO, Fair Trade ice cream ingredients
Diet soda, aspartame linked to premature deaths in women
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
Right to farm being stripped from Americans: Michigan to criminalize small family farms with chickens, goats, honey bees and more
Monsanto's seed imperialism halted in Canada thanks to massive protests
Delicious
(NaturalNews) Elan Corp. and Transition Pharmaceuticals have called a premature halt on trials on the two highest doses of their experimental Alzheimer's drug ELND005 after the deaths of nine study participants.

"Greater rates of serious adverse events, including nine deaths, were observed among patients receiving the two highest doses. A direct relationship between ELND005 and these deaths has not been established," the companies said.

The announcement was greeted as particularly bad news for Elan, which recently had to update the safety label of its multiple sclerosis drug Tysabri after studies showed a heightened risk of death among patients taking it.

Elan and Transition had already completed a successful Phase I trial of the new drug, which showed that it built up in high concentrations in the brain and appeared to preserve higher levels of a key nerve-protecting enzyme. In the Phase II trial, the companies had been testing 353 people with either 250 milligram, 1,000 milligram or 2,000 milligram doses of the drug.

The decision to halt the two higher-dose trials was made in consultation with the study's Independent Safety Monitoring Committee. As no deaths were seen in the 250 milligram group, those tests will continue.

Although there was little effect on the companies' stock prices, analysts predicted an uphill battle for approval of the experimental drug.

"This is a considerable blow for the progress of the drug," Ian Hunter of Goodbody said.

"At the very least, efficacy at the lower dose will need to be compelling to justify development and ultimate approval," said Jack Gorman of Davy Stockbrokers.

Elan is also developing another Alzheimer's drug, this one in partnership with Johnson & Johnson, but progress on that product is not nearly as advanced.

Alzheimer's disease is the most common form of dementia, affecting more than five million people in the United States alone. The disease is characterized by a progressive loss of cognitive function, and is currently incurable. An Alzheimer's drug has been called the "holy grail" for pharmaceutical companies, but so far no effective cures seem forthcoming.

Sources for this story include: www.reuters.com; www.irishtimes.com.

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.